SynthesisBMC geriatrics2026
Diagnostic performances and safety of endobronchial ultrasound-guided transbronchial needle aspiration in the older patients: a systematic review and meta-analysis.
Synthesis in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundAlthough endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is well-established for lung cancer diagnosis and staging, evidence in older patients remains limited. This study compared the diagnostic value and safety between older and younger groups.
methodsFor this systematic review and meta-analysis, we conducted a comprehensive search across databases, including PubMed, Embase, and the Cochrane Central Register. Older patients were defined as ≥ 65 or ≥ 70 years, according to study-specific criteria, and younger patients as below these thresholds. A proportional meta-analysis was performed to estimate the pooled diagnostic yield of the EBUS-TBNA.
resultsWe found six studies comprising 5,206 participants. The pooled diagnostic yield for overall diagnosis was similar between the older and younger patients (0.96 vs. 0.97; P = 0.81). The pooled diagnostic yield for malignancy detection was higher in the older patients than in the younger patients (0.59 vs. 0.51; P < 0.01). There was no significant difference in the overall complication rate between the two groups (risk ratio, 0.95; 95% confidence interval [CI], 0.74 1.23). The older group received a significantly lower average dose of midazolam compared to the younger group (mean difference [MD], − 1.11 mg; 95% CI, − 1.58 to − 0.63; P < 0.01). The duration of the procedure was comparable between the two groups (MD, − 0.03 min; 95% CI, − 1.44 1.38; P = 0.97).
conclusionsOur findings suggest that EBUS-TBNA can be safely and effectively performed in older patients, with diagnostic outcomes comparable to those in younger individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.